NeuroPace (NPCE) director Uri Geiger receives new share and option grants
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
NeuroPace Inc director Uri Geiger reported new equity awards and updated holdings. He received a grant of 2,890 shares of common stock at no cost, bringing his directly held common shares to 17,748. These shares vest in twelve equal monthly installments, subject to his continuous service.
Geiger was also granted stock options for 5,368 shares of common stock at an exercise price of $15.74 per share, expiring in 2036, which likewise vest in twelve equal monthly installments while he remains in service. Separately, 4,432,948 common shares are held indirectly through Accelmed Partners II LP, an entity over which he has sole voting and dispositive power.
Positive
- None.
Negative
- None.
Insider Trade Summary
3 transactions reported
Mixed
3 txns
Insider
Geiger Uri
Role
null
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 5,368 | $0.00 | -- |
| Grant/Award | Common Stock | 2,890 | $0.00 | -- |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Stock Option (Right to Buy) — 5,368 shares (Direct, null);
Common Stock — 17,748 shares (Direct, null);
Common Stock — 4,432,948 shares (Indirect, See footnote)
Footnotes (1)
- The shares shall vest in twelve (12) equal consecutive monthly installments until all of the shares are fully vested, subject to the Reporting Person's continuous service through each vesting date. Shares are held by Accelmed Partners II LP. Accelmed Partners II, LLC ("Accelmed LLC") is the general partner of Accelmed Partners II GP, L.P., which is the general partner of Accelmed Partners II LP. Uri Geiger is the managing partner of Accelmed LLC and has sole voting and dispositive power with respect to the shares held by Accelmed Partners II LP. Dr. Geiger, a member of our board of directors, is a General Partner at Accelmed LLC. The shares subject to the option shall vest in twelve (12) equal consecutive monthly installments until all of the option shares are fully vested and exercisable, subject to the Reporting Person's continuous service through each vesting date.
Key Figures
Common stock grant: 2,890 shares
Direct common shares after grant: 17,748 shares
Stock options granted: 5,368 options
+2 more
5 metrics
Common stock grant
2,890 shares
Awarded to Uri Geiger; vests over 12 monthly installments
Direct common shares after grant
17,748 shares
Direct NeuroPace holdings following the 2,890-share award
Stock options granted
5,368 options
Right to buy NeuroPace common stock; vests over 12 months
Option exercise price
$15.74 per share
Strike price for 5,368 stock options expiring in 2036
Indirect common share holdings
4,432,948 shares
Held by Accelmed Partners II LP with Geiger holding voting and dispositive power
Key Terms
Stock Option (Right to Buy), vesting, continuous service, dispositive power, +1 more
5 terms
Stock Option (Right to Buy) financial
"security_title: "Stock Option (Right to Buy)" for 5,368 shares"
vesting financial
"The shares shall vest in twelve (12) equal consecutive monthly installments"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
continuous service financial
"subject to the Reporting Person's continuous service through each vesting date"
dispositive power financial
"has sole voting and dispositive power with respect to the shares held"
Dispositive power is the authority to decide the final outcome of an asset, legal claim, contract, or corporate action — in effect the power to dispose of or resolve something. For investors it matters because whoever holds that authority can determine who gets paid, who controls an asset or vote, and how risks and returns are allocated; think of it like holding the key that lets you lock in the winner or loser in a deal.
indirect ownership financial
"Shares are held by Accelmed Partners II LP ... indirect holdings associated with Geiger"
FAQ
What insider transactions did NeuroPace (NPCE) director Uri Geiger report?
Uri Geiger reported equity awards from NeuroPace, including 2,890 shares of common stock and 5,368 stock options. These are compensation-related grants, not open-market purchases or sales, and vest over time based on his continued service with the company.
What are the terms of Uri Geiger’s new stock option grant at NeuroPace (NPCE)?
Geiger received stock options for 5,368 NeuroPace common shares with a $15.74 exercise price per share and a 2036 expiration. These options vest in twelve equal monthly installments, conditioned on his continuous service with the company over the vesting period.
Were Uri Geiger’s NeuroPace (NPCE) transactions open-market buys or sells?
The reported NeuroPace transactions are grants and awards, not market trades. Geiger received 2,890 common shares and 5,368 stock options as compensation, both at no purchase price, so there were no open-market buying or selling activities disclosed here.